GlobeNewswire Inc. · Jun 6, 2024
ViaDerma Provides Highlights of Quarterly Financial Report
ViaDerma provides an update on their most recent quarterly financial report
VD
OTC · VDRM
VIADERMA INC
Healthcare · Drug Manufacturers - Specialty & Generic
$0.00
Up+$0.00 (+0.00%)
Updated Aug 23, 2026, 6:56 PM
SID Score
4.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 123.37K
- P/E ratio
- -0.35
- Dividend yield
- 0.00%
- 52-week range
- — – —
- Volume
- 4.1K
- Avg. volume
- 100.63K
Price performance
VDRM price history
1M range · 0 trading sessions · Daily adjusted prices
VDRM does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
Latest VDRM news
The latest Smart Investors Daily articles mentioning VDRM.
Stock researchCompany · Overview
VDRM research
Overview
Company profile and research snapshot.
Company profile
VIADERMA INC
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
